QCRH QCR (QCRH) Insider Trading, Ownership & Congress Trades
Banks · State commercial banks · CIK 0000906465
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
104
13F, latest reported quarter
Conversions, 180 days
7
Codes C/M, not in net · $124.6K priced
What the filings say about QCRH
Insiders, 180 days
-$65.8K net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
QCR insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, QCR HOLDINGS INC insiders sold a net $65.8K of stock across 67 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Sep 5, 2025.
- The trade is 12.3% of the 6,093 shares held after it.
- No other insider sold within 30 days.
- 104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO, QCBT Ekizian Laura L sold about $71.2K of QCRH on Jun 9, 2026; 104 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Apr 23, 2026.
- The trade is 4.1% of the 1,471 shares held after it.
- No other insider bought within 30 days.
- 104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Reasner Amy L bought about $5.4K of QCRH on Jun 2, 2026; 104 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Mar 12, 2026.
- The trade is 72.4% of the 428 shares held after it.
- No other insider sold within 30 days.
- 104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, CRBT Klein James D. sold about $28.2K of QCRH on Apr 30, 2026; 104 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 7.1% of the 1,411 shares held after it.
- No other insider bought within 30 days.
- 104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Reasner Amy L bought about $8.8K of QCRH on Apr 23, 2026; 104 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 12, 2025.
- The trade is 75.1% of the 738 shares held after it.
- No other insider sold within 30 days.
- 104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, CRBT Klein James D. sold about $45.7K of QCRH on Mar 12, 2026; 104 funds added in the latest 13F quarter.67 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$65.8K over 180 days
more than 62% of Banks
Congress
no House purchase disclosed in the last 12 months
Funds
104 funds bought in last quarter
more than 55% of Banks
Revenue
+46.3% year over year
more than 94% of Banks
Margin
23.3% net margin
below 83% of Banks
Buybacks
no share repurchases reported
Short interest
3.3% of the float short (float per yahoo 2026-10-27) · 4.2 days to cover · settled 2026-10-15
more than 56% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch QCRH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+40.2%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns QCRH: institutional holders (13F)
13F holdings, latest reported quarter
1,494,502 sh
$145.5M
945,891 sh
$92.1M
915,872 sh
$89.2M
710,757 sh
$69.2M
565,893 sh
$55.1M
Congress trades in QCRH
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
QCRH planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
QCRH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
1919 Financial Services Fund
$5.0M position · as of 2026-06-30
5.2%
Mairs & Power Small Cap Fund
$8.2M position · as of 2026-06-30
3.1%
North Star Small Cap Value Fund
$986.0K position · as of 2026-05-31
2.9%
Emerald Finance & Banking Innovation Fund
$1.3M position · as of 2026-07-31
2.8%
FULLERTHALER BEHAVIORAL SMALL-MID CORE EQUITY
$10.8M position · as of 2026-06-30
2.1%
DEAN SMALL CAP VALUE
$3.9M position · as of 2026-06-30
2.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2020
$2.0M
$990.0K
$928.5K
-9%
-13%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $65.8K sold by insiders over 180 days, 104 funds added last quarter. Each figure is a federal filing, dated the day it went public.
QCRH financials
Revenue growth
+46.3%
XBRL, annual
Net margin
23.3%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$605.1M
four quarters, 2023-10-01 to 2024-09-30
Revenue, TTM QCRH
| FY Dec 2025 | $605.1M |
| FY Dec 2024 | $605.1M |
| FY Dec 2023 | $546.1M |
| FY Dec 2022 | $373.3M |
| FY Dec 2021 | $300.6M |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | $152.6M |
At each fiscal year end
Single quarter
Net margin, TTM
+23.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM QCRH
| FY Dec 2025 | +21.0% |
| FY Dec 2024 | +18.8% |
| FY Dec 2023 | +20.8% |
| FY Dec 2022 | +26.5% |
| FY Dec 2021 | +32.9% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | +18.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$792.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM QCRH
| FY Dec 2025 | $354.1M |
| FY Dec 2024 | $400.0M |
| FY Dec 2023 | $361.4M |
| FY Dec 2022 | $85.4M |
| FY Dec 2021 | $74.2M |
| Jun 2026 | $458.1M |
| Mar 2026 | -$7.9M |
| Dec 2025 | $310.8M |
| Sep 2025 | $31.7M |
| Jun 2025 | $24.2M |
| Mar 2025 | -$12.7M |
| Dec 2024 | $163.4M |
| Sep 2024 | $229.9M |
At each fiscal year end
Single quarter
Debt to equity
0.01x
current debt only, 2026-06-30; equity 2026-06-30
Debt to equity QCRH
| FY Dec 2025 | 0.00x |
| FY Dec 2024 | 0.00x |
| FY Dec 2023 | 0.00x |
| FY Dec 2022 | 0.17x |
| FY Dec 2021 | 0.01x |
| Jun 2026 | 0.01x |
| Mar 2026 | 0.00x |
| Dec 2025 | 0.00x |
| Sep 2025 | 0.00x |
| Jun 2025 | 0.00x |
| Mar 2025 | 0.00x |
| Dec 2024 | 0.00x |
| Sep 2024 | 0.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
96.41x
TTM operating cash flow over current debt only, 2026-06-30
Cash flow to debt QCRH
| FY Dec 2025 | 159.07x |
| FY Dec 2024 | 246.97x |
| FY Dec 2023 | 250.88x |
| FY Dec 2022 | 0.92x |
| FY Dec 2021 | 23.22x |
| Jun 2026 | 96.41x |
| Mar 2026 | 220.25x |
| Dec 2025 | 159.07x |
| Sep 2025 | 92.44x |
| Jun 2025 | 336.39x |
| Mar 2025 | 213.78x |
| Dec 2024 | 246.97x |
| Sep 2024 | 202.98x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity QCRH
| FY Dec 2025 | +12.1% |
| FY Dec 2024 | +12.1% |
| FY Dec 2023 | +13.7% |
| FY Dec 2022 | +13.7% |
| FY Dec 2021 | +15.6% |
| Jun 2026 | +12.9% |
| Mar 2026 | +12.6% |
| Dec 2025 | +12.1% |
| Sep 2025 | +11.8% |
| Jun 2025 | +11.4% |
| Mar 2025 | +11.7% |
| Dec 2024 | +12.1% |
| Sep 2024 | +12.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets QCRH
| FY Dec 2025 | +1.4% |
| FY Dec 2024 | +1.3% |
| FY Dec 2023 | +1.4% |
| FY Dec 2022 | +1.4% |
| FY Dec 2021 | +1.7% |
| Jun 2026 | +1.5% |
| Mar 2026 | +1.4% |
| Dec 2025 | +1.4% |
| Sep 2025 | +1.3% |
| Jun 2025 | +1.3% |
| Mar 2025 | +1.3% |
| Dec 2024 | +1.3% |
| Sep 2024 | +1.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital QCRH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed QCRH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.20x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing QCRH
| FY Dec 2025 | 11.11x |
| FY Dec 2024 | 12.02x |
| FY Dec 2023 | 8.69x |
| FY Dec 2022 | 8.65x |
| FY Dec 2021 | 9.00x |
| Jun 2026 | 11.52x |
| Mar 2026 | 10.72x |
| Dec 2025 | 11.11x |
| Sep 2025 | 10.56x |
| Jun 2025 | 10.23x |
| Mar 2025 | 10.72x |
| Dec 2024 | 12.02x |
| Sep 2024 | 10.76x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.6B
market value at close 2026-10-26 on 2026-07-31 shares, plus current debt only, 2026-06-30, minus cash 2018-12-31
Enterprise value QCRH
| FY Dec 2025 | $1.3B |
| FY Dec 2024 | $1.3B |
| FY Dec 2023 | $893.0M |
| FY Dec 2022 | $882.2M |
| FY Dec 2021 | $791.7M |
| Jun 2026 | $1.5B |
| Mar 2026 | $1.3B |
| Dec 2025 | $1.3B |
| Sep 2025 | $1.2B |
| Jun 2025 | $1.1B |
| Mar 2025 | $1.1B |
| Dec 2024 | $1.3B |
| Sep 2024 | $1.2B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+47.0%
TTM free cash flow over market value at close 2026-10-26
FCF yield QCRH
| FY Dec 2025 | +25.2% |
| FY Dec 2024 | +29.4% |
| FY Dec 2023 | +37.0% |
| FY Dec 2022 | +10.2% |
| FY Dec 2021 | +8.5% |
| Jun 2026 | +49.3% |
| Mar 2026 | +25.1% |
| Dec 2025 | +25.2% |
| Sep 2025 | +16.1% |
| Jun 2025 | +35.2% |
| Mar 2025 | +32.9% |
| Dec 2024 | +29.4% |
| Sep 2024 | +41.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.45x
P/E over trailing EPS growth of 27%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing QCRH
| FY Dec 2025 | 0.94x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.51x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.14x |
| Jun 2026 | 0.42x |
| Mar 2026 | 0.54x |
| Dec 2025 | 0.94x |
| Sep 2025 | 2.60x |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 1.61x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | n/a | n/a | $546.1M | $373.3M |
| Net income | $127.2M | $113.8M | $113.6M | $99.1M |
| EPS (diluted) | 7.49 | 6.71 | 6.73 | 5.87 |
| Operating cash flow | $421.5M | $444.5M | $376.3M | $118.7M |
SEC XBRL, fiscal years, as known on 2026-10-28
QCRH Stock Sonar score 6/7 axes
Find similar shapesCompareQCRH ranks highest on growth (94th percentile) and financial health (91st), and lowest on insider conviction (54th), among Banks peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
QCRH filings, in plain words
Are QCR insiders buying or selling QCRH?
In the 180 days to 2026-10-28, QCR insiders were net sellers, a net $65.8K: $5.4K of purchases and $71.2K of sales reported on Form 4, by 1 buyer and 1 seller.
Read the full summary
In the 180 days to 2026-10-28, QCR insiders were net sellers of QCRH, a net $65.8K across purchases and sales reported on Form 4 by 1 buyer and 1 seller. Sales outweighed purchases more than tenfold by value. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
